Cargando…
Gene Therapy Corrects Mitochondrial Dysfunction in Hematopoietic Progenitor Cells and Fibroblasts from Coq9(R239X) Mice
Recent clinical trials have shown that in vivo and ex vivo gene therapy strategies can be an option for the treatment of several neurological disorders. Both strategies require efficient and safe vectors to 1) deliver the therapeutic gene directly into the CNS or 2) to genetically modify stem cells...
Autores principales: | Barriocanal-Casado, Eliana, Cueto-Ureña, Cristina, Benabdellah, Karim, Gutiérrez-Guerrero, Alejandra, Cobo, Marién, Hidalgo-Gutiérrez, Agustín, Rodríguez-Sevilla, Juan José, Martín, Francisco, López, Luis C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920430/ https://www.ncbi.nlm.nih.gov/pubmed/27341668 http://dx.doi.org/10.1371/journal.pone.0158344 |
Ejemplares similares
-
β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9
(R239X) mice
por: Hidalgo‐Gutiérrez, Agustín, et al.
Publicado: (2018) -
Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis
por: Rodríguez-Hidalgo, María, et al.
Publicado: (2018) -
β-RA Targets Mitochondrial Metabolism and Adipogenesis, Leading to Therapeutic Benefits against CoQ Deficiency and Age-Related Overweight
por: Hidalgo-Gutiérrez, Agustín, et al.
Publicado: (2021) -
A Chimeric HS4-SAR Insulator (IS2) That Prevents Silencing and Enhances Expression of Lentiviral Vectors in Pluripotent Stem Cells
por: Benabdellah, Karim, et al.
Publicado: (2014) -
The Q-junction and the inflammatory response are critical pathological and therapeutic factors in CoQ deficiency
por: González-García, Pilar, et al.
Publicado: (2022)